A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
Clinical trial NCT00282243 · COMPLETED
Trial details
- NCT number
- NCT00282243
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2008-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.